Karyopharm Therapeutics
NASDAQ: KPTI
Healthcare
Biotechnology
Rank
#28488
Market Cap
51.55 M
Volume
62,645
Price
6.02
Change (%)
2.20%
Country or region
United States
United States
Karyopharm Therapeutics Stock Split History Overview
This company has undergone a total of one stock splits throughout its history. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on February 26, 2025 with a ratio of 1-for-15. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Karyopharm Therapeutics (NASDAQ: KPTI) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| February 26, 2025 | 1:15 | x0.06666667 | x0.06666667 | Reverse |
Frequently Asked Questions
If Karyopharm Therapeutics (stock symbol: NASDAQ: KPTI) had never undergone any stock splits, its price per share today would be approximately 0.40 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-15) that occurred on February 26, 2025.
Karyopharm Therapeutics (stock symbol: NASDAQ: KPTI) has undergone a total of one stock splits. The most recent split occurred on February 26, 2025. One share bought prior to the first split on February 26, 2025 would now equal 0.07 shares.
Karyopharm Therapeutics (stock symbol: NASDAQ: KPTI) has undergone one stock splits in its history. The most recent split, a 1-for-15 split, occurred on February 26, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
